Difficulty: Medium
Average Score: 87%
Practice
Which of the following insulins can be administered intravenously?
Correct answer
A
Rationale
In endocrine pharmacology, understanding the administration routes of different types of insulins is crucial for safe and effective patient care. The correct answer to the question of which insulin can be administered intravenously is A) Regular insulin.
Regular insulin is a short-acting, fast-onset insulin that can be given intravenously for rapid effect in emergency situations such as diabetic ketoacidosis (DKA) or severe hyperglycemia. When administered intravenously, regular insulin has a quick onset of action, making it the preferred choice in critical situations where immediate blood glucose lowering is necessary.
Regarding the other options:
- B) Isophane insulin (NPH) is an intermediate-acting insulin and is not recommended for intravenous administration due to its slower onset and longer duration of action.
- C) Protamine zinc insulin (PZI) is a long-acting insulin and is not suitable for intravenous use as it is designed for subcutaneous administration to provide a prolonged effect.
- D) Semilente insulin is an intermediate-acting insulin and is not intended for intravenous administration because of its slower onset and longer duration compared to regular insulin.
Educationally, understanding the specific characteristics of each type of insulin and their appropriate routes of administration is essential for healthcare professionals to ensure patient safety and optimal treatment outcomes. Knowing when to use regular insulin intravenously versus subcutaneously can be life-saving in critical care scenarios. This knowledge helps healthcare providers make informed decisions in managing patients with diabetes and related endocrine disorders.
Regular insulin is a short-acting, fast-onset insulin that can be given intravenously for rapid effect in emergency situations such as diabetic ketoacidosis (DKA) or severe hyperglycemia. When administered intravenously, regular insulin has a quick onset of action, making it the preferred choice in critical situations where immediate blood glucose lowering is necessary.
Regarding the other options:
- B) Isophane insulin (NPH) is an intermediate-acting insulin and is not recommended for intravenous administration due to its slower onset and longer duration of action.
- C) Protamine zinc insulin (PZI) is a long-acting insulin and is not suitable for intravenous use as it is designed for subcutaneous administration to provide a prolonged effect.
- D) Semilente insulin is an intermediate-acting insulin and is not intended for intravenous administration because of its slower onset and longer duration compared to regular insulin.
Educationally, understanding the specific characteristics of each type of insulin and their appropriate routes of administration is essential for healthcare professionals to ensure patient safety and optimal treatment outcomes. Knowing when to use regular insulin intravenously versus subcutaneously can be life-saving in critical care scenarios. This knowledge helps healthcare providers make informed decisions in managing patients with diabetes and related endocrine disorders.